equity investment

The company said it would use the funding to continue development of its human microbiome research kits, protocols, and software.

Mayo Clinic is taking an ownership stake in sequencing startup Veritas Genetics as it integrates genomics expertise into the myGenome WGS platform.

The financing, led by new investor Foresite Capital, will help DNAnexus deploy its genome informatics technology and expand its clinical trials presence.

The companies partnered last month to develop new personalized cancer diagnostics using the Helomics D-Chip bioinformatics platform.

Luna DNA is a startup genomic and medical research firm that has created a blockchain-based cryptocurrency to reward people for contributing DNA data.

The company will use the money to bring its Elsie genomic information platform to markets internationally.

Envisagenics, which was spun out of Cold Spring Harbor Laboratory, has developed a platform to help drug companies address RNA splicing errors.

Syapse has raised new venture capital to support expansion into community hospitals that want to start precision oncology programs.

Counsyl Raises $80M

The new funding comes from life sciences investment firm Perceptive Advisors. Home Care Assistance CEO Lily Sarafan has also joined Counsyl's board. 

The funding will go toward bringing the BA100 test to clinicians. The test can identify patients most likely to respond to the standard of care chemotherapy treatment.

Pages

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.